GRANULES INDIA LTD.-$ - 532482 - Board declares Third Interim Dividend
Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 28, 2021, inter alia, has declared third interim dividend of 25 paise per share of face value of Re. 1/- each representing 25% of paid-up capital for the financial year 2020-21. GRANULES INDIA LTD.-$ - 532482 - The Board Of Directors Fixed The Record Date As 09Th February 2021 For The Purpose Of Payment Of Third Interim Dividend For The Financial Year 2020-21
The Board of Directors fixed the record date as 09th February 2021 for the purpose of payment of third interim dividend for the financial year 2020-21 GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to the Analysts/Investors with regard to Un-audited financial results for the third quarter ended December 31, 2020 GRANULES INDIA LTD.-$ - 532482 - Outcome Of 204Th Board Meeting Dated 28Th January 2021
Outcome of 204th Board meeting dated 28th January 2021 GRANULES INDIA LTD.-$ - 532482 - Financial Results For The Quarter Ended December 30, 2020
Financial Results for the quarter ended December 30, 2020 GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Earnings Conference call for Q3, FY 2020-21 Granules India gets USFDA nod for Metformin Hydrochloride tablets
Drug is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; had US sales of about $192 mn for 12 months ending November 2020 GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for Inter-Alia, To Consider And Approve The Un-Audited Financial Results For The Third Quarter Ended December 31, 2020 And The Payment Of Third Interim Dividend For The FY 2020-21, If Any.
GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2021 ,inter alia, to consider and approve the Un-audited Financial Results for the third quarter ended December 31, 2020 and the payment of third interim dividend for the FY 2020-21, if any GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited announces USFDA approval of Metformin Hydrochloride ER Tablets USP, 500 mg and 1000 mg GRANULES INDIA LTD.-$ - 532482 - Shareholding for the Period Ended December 31, 2020
Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here